A Multicenter, Randomized, Double-Blind Study to Evaluate Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
A Multicenter, Randomized, Double-Blind Study to Evaluate Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
This study will evaluate higher versus standard adalimumab dosing regimens for induction and maintenance therapy in subjects with moderately to severely active Crohn's Disease and evidence of mucosal ulceration.
Inclusion Criteria:
Exclusion Criteria:
Chicago, Illinois 60611-2927, United States
Urbana, Illinois 61801, United States
Chevy Chase, Maryland 20815, United States
Great Neck, New York 11021, United States
Charlotte, North Carolina 28207, United States
Milwaukee, Wisconsin 53215, United States
Innsbruck, 6020, Austria
Calgary, Alberta T2N 4Z6, Canada
Montreal, Quebec H3G 1A4, Canada
Ústí nad Labem, 401 13, Czechia
Vandœuvre-lès-Nancy, Meurthe-et-Moselle 54511, France
Petakh Tikva, Tel Aviv 4941492, Israel
San Giovanni Rotondo, 71013, Italy
San Juan, 00935, Puerto Rico
Kharkiv, Kharkiv Oblast 61039, Ukraine
Kherson, 73000, Ukraine
Southampton, SO16 6YD, United Kingdom